Ethnic disparities in people accessing FreeStyle Libre in the United Kingdom: Insights from the Association of British Clinical Diabetologists audit
(2023)
Journal Article
Deshmukh, H., Adeleke, K. A., Ssemmondo, E., Wilmot, E. G., Shah, N., Pieri, B., …Sathyapalan, T. (2023). Ethnic disparities in people accessing FreeStyle Libre in the United Kingdom: Insights from the Association of British Clinical Diabetologists audit. Diabetic medicine, 40(8), Article e15095. https://doi.org/10.1111/dme.15095
All Outputs (11)
Impaired awareness of hypoglycaemia: Prevalence and associated factors before and after FreeStyle Libre use in the Association of British Clinical Diabetologists audit (2022)
Journal Article
Pieri, B., Deshmukh, H., Wilmot, E. G., Choudhary, P., Shah, N., Gregory, R., …Sathyapalan, T. (2023). Impaired awareness of hypoglycaemia: Prevalence and associated factors before and after FreeStyle Libre use in the Association of British Clinical Diabetologists audit. Diabetes, Obesity and Metabolism, 25(1), 302-305. https://doi.org/10.1111/dom.14841
Angiopoietin-1: an early biomarker of diabetic nephropathy? (2021)
Journal Article
Butler, A. E., Al-Qaissi, A., Sathyapalan, T., & Atkin, S. L. (2021). Angiopoietin-1: an early biomarker of diabetic nephropathy?. Journal of Translational Medicine, 19(1), https://doi.org/10.1186/s12967-021-03105-9
Impaired Awareness of Hypoglycemia and Severe Hypoglycemia in Drivers With Diabetes: Insights From the Association of British Clinical Diabetologists Nationwide Audit (2021)
Journal Article
Deshmukh, H., Wilmot, E. G., Choudhary, P., Narendran, P., Shah, N., Barnes, D., …Sathyapalan, T. (2021). Impaired Awareness of Hypoglycemia and Severe Hypoglycemia in Drivers With Diabetes: Insights From the Association of British Clinical Diabetologists Nationwide Audit. Diabetes Care, 44(11), e190-e191. https://doi.org/10.2337/dc21-1181
Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia (2021)
Journal Article
Moin, A. S. M., Al-Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021). Glucose excursions in type 2 diabetes modulate amyloid-related proteins associated with dementia. Journal of Translational Medicine, 19(1), Article 131. https://doi.org/10.1186/s12967-021-02797-3
Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome (2021)
Journal Article
Moin, A. S. M., Nandakumar, M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (in press). Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome. Journal of Translational Medicine, 19(1), Article 63. https://doi.org/10.1186/s12967-021-02723-7
COVID-19 biomarkers for severity mapped to polycystic ovary syndrome (2020)
Journal Article
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2020). COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. Journal of Translational Medicine, 18(1), Article 490. https://doi.org/10.1186/s12967-020-02669-2
Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity (2020)
Journal Article
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2020). Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity. Metabolism, 112, Article 154374. https://doi.org/10.1016/j.metabol.2020.154374
Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome (2016)
Journal Article
Sathyapalan, T., Dakroury, Y., Ahmed, L., Elshewehy, A. M. M., Kilpatrick, E. S., Coady, A., & Atkin, S. L. (2016). Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. Clinical Endocrinology, 85(4), 671-673. https://doi.org/10.1111/cen.13120There is evidence from animal and in-vitro studies that activation of the endocannabinoid system (EC) through cannabinoid receptor 1 (CB-1) is associated with liver injury, inflammation and hepatocellular carcinoma.1 Data suggests endogenous cannabin... Read More about Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.
Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes (2010)
Journal Article
Sathyapalan, T., Manuchehri, A. M., Rigby, A. S., & Atkin, S. L. (2010). Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes. Diabetes Care, 33(3), e37-e37. https://doi.org/10.2337/dc09-1555
Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations (2007)
Journal Article
Manuchehri, A. M., Sathyapalan, T., Jayagopal, V., Kilpatrick, E. S., Ghatei, M. A., Bloom, S. R., & Atkin, S. L. (2008). Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations. Clinical Endocrinology, 68(5), 836-838. https://doi.org/10.1111/j.1365-2265.2007.03093.x